Drugs / HYAJOINT Plus
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04931719 | Jul 2019 → Jun 2020 | osteoarthritis, knee | Kaohsiung Veterans General Hospital. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HYA-JOINT Plus | “single intra-articular injection of a novel cross-linked hyaluronan (HYA-JOINT Plus) with a single injection of Synvisc-One in patients with knee osteoarthritis.” PMID 28291178 ↗ Mar 2017 |
| Modality | Other / unclassified | “single intraarticular cross-linked HA (HYAJOINT Plus, 3 ml, 20 mg/ml)” PMID 36329428 ↗ Nov 2022 |
| Route | Other | “one intraarticular HYAJOINT Plus injection (3ml)” NCT04931719 ↗ |